‹ Screener

POSITRON CORP

POSC · Electromedical & Electrotherapeutic Apparatus · 32.8M shares · EDGAR filings ↗

Grade

F30

Positron — distressed micro medical-imaging firm with negative gross margin.

Strengths

Risks

Notable findings

Quarterly revenue

2015-06-30 · $328K2015-09-30 · $304K2025-03-31 · $119K2026-03-31 · $111K

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
-458.2%
Operating margin
-2275.1%
Net margin
-2297.8%
Return on equity
-734.4%
Return on assets
-265.1%
ROIC
-519.2%
Revenue growth (QoQ)
-7.0%
Debt / equity
0.1×
Interest coverage
-83.8×
Current ratio
1.4×
Tangible book value
$1M
Stock comp / revenue
1079.8%

Supply chain

Customers (0)

    Suppliers (2)

    • Neusoft Medical Systems
    • Shenyang Intelligent Nuclear Medical Technology Co. Ltd.

    Named in the 10-K; linked when we track them.

    Notable events (8-K)

    DateItems
    2025-12-30Material agreement3.02Exhibitsfiling ↗
    2025-12-16Auditor changeExhibitsfiling ↗
    2018-08-01Material agreementBankruptcyResultsExec/director changeShareholder voteExhibitsfiling ↗
    2016-05-10Material agreementBankruptcyExhibitsfiling ↗
    2016-02-22Exec/director changefiling ↗
    2015-10-05Exec/director changefiling ↗
    2015-09-11Otherfiling ↗
    2014-12-22Exec/director changefiling ↗

    Recent filings

    FormFiledPeriodAccession
    10-Q2026-05-152026-03-310001539497-26-001456 ↗
    10-K2026-03-312025-12-310001539497-26-001063 ↗
    8-K2025-12-302025-12-230001539497-25-003364 ↗
    8-K2025-12-162025-12-100001539497-25-003303 ↗
    8-K2018-08-012018-07-310001615774-18-007286 ↗
    8-K2016-05-102016-05-040001144204-16-100561 ↗
    8-K2016-02-222016-02-160001144204-16-083647 ↗
    10-Q2015-11-232015-09-300001144204-15-067560 ↗
    8-K2015-10-052015-09-210001144204-15-058036 ↗
    8-K2015-09-112015-09-080001144204-15-054630 ↗
    10-Q2015-08-142015-06-300001144204-15-049684 ↗
    10-Q2015-05-152015-03-310001144204-15-031752 ↗